Hyperion Defi HYPD
NASDAQ HYPD
$3.13 -0.01 (-0.31%)
As of: Aug 21, 2026 · 2:27 PM EDT

Hyperion Defi (HYPD) Net Margin Growth (1y) (2024 - 2026)

Hyperion Defi (HYPD) Net Margin Growth (1y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.90 Bn 131.05 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 86.10 Bn 78.11 Bn 3.93 Bn -763.00
3 Argenx Se 65.56 Bn 60.37 Bn 1.37 Bn 529.00
4 Moderna 55.82 Bn 50.68 Bn 52.00 Mn 4,168.00
5 BeOne Medicines 42.14 Bn 37.04 Bn 1.53 Bn 673.00
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn 2,208.00
7 BioNTech SE 27.74 Bn 9.35 Bn 668.28 Mn -1,652.00
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn 29,636.00
9 Royalty Pharma 27.38 Bn 26.54 Bn - -392.00
10 Hyperion Defi 44.65 Mn 35.01 Mn 357,693.00 -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.50 Mn
Dec 31, 2025 6.29 Mn
Sep 30, 2025 48.73 Mn
Mar 31, 2025 21.95 Mn
Dec 31, 2024 23.55 Mn
Sep 30, 2024 9.81 Mn